A carregar...
Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis
Background: Dalfampridine extended release (ER) improves walking in people with multiple sclerosis (MS), as demonstrated by walking speed improvement. This exploratory study evaluated treatment effects of dalfampridine-ER on gait, balance, and walking through treatment withdrawal and reinitiation. M...
Na minha lista:
| Publicado no: | Int J MS Care |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Consortium of Multiple Sclerosis Centers
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673920/ https://ncbi.nlm.nih.gov/pubmed/26664333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2014-036 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|